Cargando…

A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer

PANoptosis, a programmed cell death, shares key characteristics of apoptosis, pyroptosis, and necroptosis. Accumulating evidence suggests that PANoptosis plays a crucial role in tumorigenesis. However, the respective regulation mechanisms in cancer are so far unclear. Using various bioinformatic app...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Lingling, Sun, Qiran, Huang, Shenglan, Hu, Lanyan, Chen, Qi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995449/ https://www.ncbi.nlm.nih.gov/pubmed/36890219 http://dx.doi.org/10.1038/s41598-023-30934-z

Ejemplares similares

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

NLRP12‐PANoptosome in haemolytic, infectious and inflammatory diseases
por: Tweedell, Rebecca E., et al.
Publicado: (2023)

Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
por: Zhao, Xiashuang, et al.
Publicado: (2023)

The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)
por: Samir, Parimal, et al.
Publicado: (2020)

Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)
por: Christgen, Shelbi, et al.
Publicado: (2020)

Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response
por: Zheng, Hong, et al.
Publicado: (2023)

Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients
por: Huang, Shenglan, et al.
Publicado: (2021)

Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
por: Tu, Zewei, et al.
Publicado: (2023)

Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers
por: Cai, Yuan, et al.
Publicado: (2022)

Comprehensive analysis of PILRΑ’s association with the prognosis, tumor immune infiltration, and immunotherapy in pan-cancer
por: Li, Qiao, et al.
Publicado: (2023)

Pan-Cancer Analysis Predicts FOXS1 as a Key Target in Prognosis and Tumor Immunotherapy
por: Liu, Yunqiang, et al.
Publicado: (2022)

Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis
por: Ye, Yingquan, et al.
Publicado: (2022)

Roles of HMGBs in Prognosis and Immunotherapy: A Pan-Cancer Analysis
por: Lin, Tong, et al.
Publicado: (2021)

Pan-cancer analysis of ADAMs: A promising biomarker for prognosis and response to chemotherapy and immunotherapy
por: Ma, Bo, et al.
Publicado: (2023)

Sperm Autoantigenic Protein 17 Predicts the Prognosis and the Immunotherapy Response of Cancers: A Pan-Cancer Analysis
por: Tu, Zewei, et al.
Publicado: (2022)

Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy
por: Wei, Wei, et al.
Publicado: (2022)

Pan-Cancer Analysis of the Characteristics of LY96 in Prognosis and Immunotherapy Across Human Cancer
por: Nie, Kechao, et al.
Publicado: (2022)

YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021)

Pan-cancer analysis identifies the correlations of Thymosin Beta 10 with predicting prognosis and immunotherapy response
por: Li, Zhanzhan, et al.
Publicado: (2023)

Pan-Cancer Analysis of the Oncogenic and Immunological Role of RCN3: A Potential Biomarker for Prognosis and Immunotherapy
por: Ding, Jian, et al.
Publicado: (2022)

Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity
por: Liu, Ting, et al.
Publicado: (2023)

Systematic analysis of the necroptosis index in pan-cancer and classification in discriminating the prognosis and immunotherapy responses of 1716 glioma patients
por: Ma, Shuai, et al.
Publicado: (2023)

Systematic analysis reveals a pan-cancer SNHG family signature predicting prognosis and immunotherapy response
por: Zheng, Haotian, et al.
Publicado: (2023)

Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2(RRM2) gene correlates with prognosis and tumor immunotherapy in pan-cancer
por: Wu, Liyuan, et al.
Publicado: (2022)

Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
por: Liu, Aibin, et al.
Publicado: (2022)

Comprehensive analysis of the expression and prognosis for APOE in malignancies: A pan-cancer analysis
por: YU, SHOUKAI, et al.
Publicado: (2022)

A pan‐cancer blueprint of genomics alterations and transcriptional regulation of Siglecs, and implications in prognosis and immunotherapy responsiveness
por: Mei, Song, et al.
Publicado: (2023)

Pan-cancer analysis of Homeobox B9 as a predictor for prognosis and immunotherapy in human tumors
por: Jin, Qingdong, et al.
Publicado: (2023)

Pan-cancer analysis of TASL: a novel immune infiltration-related biomarker for tumor prognosis and immunotherapy response prediction
por: Li, Huanyu, et al.
Publicado: (2023)

A Comprehensive Pan-Cancer Analysis of the Potential Biological Functions and Prognosis Values of RICTOR
por: Sun, Ying, et al.
Publicado: (2023)

A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma
por: Huang, Shenglan, et al.
Publicado: (2022)

Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response
por: Tong, Wen, et al.
Publicado: (2022)

Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy
por: Liu, Jinhui, et al.
Publicado: (2022)

Corrigendum: A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma
por: Huang, Shenglan, et al.
Publicado: (2022)

Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer
por: Ju, Mingyi, et al.
Publicado: (2020)

Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
por: Wang, Yuqi, et al.
Publicado: (2023)

GIMAP7 as a Potential Predictive Marker for Pan-Cancer Prognosis and Immunotherapy Efficacy
por: Qin, Yan, et al.
Publicado: (2022)

Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma
por: Nan, Han, et al.
Publicado: (2023)

Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer
por: Zhang, Wenbing, et al.
Publicado: (2023)

Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy
por: Li, Kuangxun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hj2io9qrj42usnjkeccfpicksg